Loading clinical trials...
Loading clinical trials...
A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors
Conditions
Interventions
XL647
Locations
2
United States
Stanford University Medical Center
Stanford, California, United States
Mayo Clinic
Rochester, Minnesota, United States
Start Date
June 1, 2004
Primary Completion Date
July 1, 2007
Completion Date
November 1, 2007
Last Updated
May 13, 2022
NCT06696768
NCT07061964
NCT05198830
NCT05372640
NCT05245812
NCT03375307
Lead Sponsor
Kadmon Corporation, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions